Why Choose Auburn Pharmaceutical?

  • No Contracts!
  • Hassle Free Return Policy
  • Great Savings on Short Date Items
  • Great Value on Close-out Items
  • Free Shipping (orders of $75 or more)
  • Over 3,000 AB Rated Generics
  • Pedigree Available on our Generics
  • Fully Accredited
  • VAWD Accredited

Auburn Pharmaceutical has become one of the fastest growing generic distributors in the country. We proudly serve over 2,500 independent pharmacies, chains, hospitals and governmental agencies.

Auburn Pharmaceutical is a family-owned and operated business, established in 1993. The family has been involved in the generic pharmaceutical industry for over 45 years.

See why Auburn Pharmaceutical is "DIFFERENT" from the rest. Register and get started today!

"I have had superb experience with Auburn, especially with our rep, due to the company's general values, deals and personal ability"
Ryan from Wisconsin

"Auburn is very competitive with pricing as well as great customer service. The sales rep I have is personable and courteous"
Jay from Kentucky

"It has been a very positive, professional and enjoyable experience dealing with the company and particularly our rep, she's a delight"
Camille from Ohio

"Ordering through Auburn has always been an easy experience. The staff is friendly with no pressure to buy, but knowledgeable on specials and upcoming shortages."
Lorraine from Michigan

FDA has collected more than $255 million in generic drug user fees

The Food and Drug Administration's Center for Drug Evaluation and Research has collected 84% of the fees it intends to collect this year under a law passed last year to collect user fees from generic drug members, according to a memo sent out to CDER staff Tuesday.

read more

Tuesday June 18, 2013

Royalty Pharma drops bid for Elan Corp.

Royalty Pharma will not buy Irish drug maker Elan Corp., the company said Tuesday.

read more

Tuesday June 18, 2013

Avella joins limited-distribution network for orally administered cancer drug

Avella Specialty Pharmacy will be included in the limited distribution network for a cancer drug made by Genentech, Avella said Tuesday.

read more

Tuesday June 18, 2013

Teva to acquire MicroDose for up to $165 million

Teva Pharmaceutical Industries will spend up to $165 million to buy a company developing a drug to prevent viral respiratory infections.

read more

Tuesday June 18, 2013